Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study.
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationRacial Disparity in Stroke Awareness in the US: An Analysis of the 2014 National Health Interview SurveyHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationBlood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study.Construct validity of cognitive reserve in a multiethnic cohort: The Northern Manhattan Study.Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study.Extreme deep white matter hyperintensity volumes are associated with African American raceNeglect performance in acute stroke is related to severity of white matter hyperintensities.Ultrasound Markers of Carotid Atherosclerosis and Cognition: The Northern Manhattan Study.African Caribbeans have greater subclinical cerebrovascular disease than Europeans: this is associated with both their elevated resting and ambulatory blood pressure and their hyperglycaemiaVascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.Quality of life declines after first ischemic stroke. The Northern Manhattan StudyLipid profile components and subclinical cerebrovascular disease in the northern Manhattan studyPreventing vascular effects on brain injury and cognition late in life: knowns and unknowns.Non-high-density lipoprotein cholesterol on the risks of stroke: a result from the Kailuan study.Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study.Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study.Cooccurrence of vascular risk factors and late-life white-matter integrity changes.Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'.Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudyDoes Stroke Contribute to Racial Differences in Cognitive Decline?Using contextual analyses to examine the meaning of neuropsychological variables across samples of english-speaking and spanish-speaking older adults.Differences in the distribution of stroke subtypes in a UK black stroke population - final results from the South London Ethnicity and Stroke Study.Association of prediabetes and diabetes with stroke symptoms: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study.Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysisPatent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohortHypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the FutureClinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individualsPrevalence and correlates of silent cerebral infarcts in the Framingham offspring study.Blood pressure levels and stroke: J-curve phenomenon?Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study.Racial Differences in Gray Matter Integrity by Diffusion Tensor in Black and White Octogenarians.Effect of sex and age interactions on functional outcome after stroke.Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort.Stroke in Indigenous Africans, African Americans, and European Americans: Interplay of Racial and Geographic Factors.
P2860
Q22306356-CFD1EE24-4ACF-4AD8-87DA-5B068F4BEA89Q28385464-3367C538-9353-45C8-A4F7-1065778493FFQ29547691-8B6E7B34-30DB-4345-A858-316F805EE13EQ29547909-FFE4DC97-B72B-4305-8E56-BC58246DA6C3Q30238784-04081BC2-8D66-471F-8B29-0197D1FB670BQ33578128-D5F2DE8B-23C5-41B7-91C3-4A87E88B9171Q33578153-DA9EB115-D1E3-4A2F-96AF-FC356C9F0108Q33697952-475E2841-0231-4067-B085-662677356E1AQ33745467-2C2AE451-37B3-42DA-894D-F9CB7C26C3B0Q33760741-5615DC5C-46DE-4276-BA0E-0E62965724A1Q33829155-0E87F68B-74E8-4CE2-9793-B7EB45E003EAQ33847056-280D1AB8-EAFE-4626-ABC9-DF3EB890BC9BQ33967781-A7784805-578A-4C85-A4B5-EA95C2C3651BQ34054964-20545999-1A1F-46FA-B23D-E8F2B031B6E6Q34079466-F229AE5D-4965-4EB6-9B7E-74D230180DD4Q34212947-3F716C06-BAB7-462A-B915-F8539D572CD3Q34994840-2883C28D-DEA3-435A-B56B-9DB4101DEB7FQ35034847-053B508D-EBC4-4280-96B2-839508A413D4Q35208649-67E8EB02-42EA-48B0-91B5-DE377C835AE7Q35236199-13853864-E3FA-4189-BDAC-12E77E9F0D2BQ35581060-E5F821E2-BD25-4457-87C0-BB9CF956A6AAQ35697860-F2A8394C-1E32-4A5E-95E0-8D1272C0E752Q35779069-BCD9FFC0-F700-40B5-932D-5FEF2375E3FEQ36018978-2C772F38-52BC-4B5C-BF62-8AEB63924045Q36022998-9A2CE6C8-0C45-4E51-AD14-3DEC3A3955BEQ36181345-B291CD69-2770-4BA9-BF6E-22F04FB82C72Q36435485-053DDC00-1242-4491-BC1B-2B7140EB4CDCQ36739628-06D2C8D5-51C3-4157-AA02-FE479BC98915Q36807001-2E9A25EF-B801-4C11-B58D-ED0CC11F6326Q36966359-A9197DC8-3E78-4350-B70E-F883F550AD6CQ37184753-960199D8-3A83-4F26-871A-E9EDB870256FQ37205835-CE29B2D1-22E2-4525-B741-935FA7447E9DQ37265840-5D502BAD-F498-40D9-BE0A-C1BF830124EEQ37337561-69175D5C-EE10-4395-BFF8-4193651C65BEQ37364397-ACCFC4C7-5331-4E0D-A200-74A86BDCF301Q37452118-1A9686FC-E7D8-4A9F-B542-03C3B4DA34ACQ38268937-5D42644C-BA18-431C-AAA3-5403B6C38F0EQ38406405-740B3F08-AA3E-499D-A86B-86505D2AE5BDQ38798603-3948F0ED-5189-4BDC-83B1-5B035D20B6A2Q38847134-D29F3FFE-F99B-4FF0-A8A2-2B375C1714E1
P2860
Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence and determinants of ...... the Northern Manhattan Study.
@en
Prevalence and determinants of ...... the Northern Manhattan Study.
@nl
type
label
Prevalence and determinants of ...... the Northern Manhattan Study.
@en
Prevalence and determinants of ...... the Northern Manhattan Study.
@nl
prefLabel
Prevalence and determinants of ...... the Northern Manhattan Study.
@en
Prevalence and determinants of ...... the Northern Manhattan Study.
@nl
P2093
P2860
P1433
P1476
Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study
@en
P2093
P2860
P304
P356
10.1212/01.WNL.0000277521.66947.E5
P407
P577
2007-09-26T00:00:00Z